Changes in serum receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and interleukin-6 levels in patients with glucocorticoid-induced osteoporosis treated with human parathyroid hormone (1-34)

The Journal of Clinical Endocrinology and Metabolism
Eric C BuxtonN E Lane

Abstract

Changes in biochemical markers of bone turnover following intermittent injections of human (h)PTH (1-34) suggest that bone formation is initially favored over bone resorption. hPTH (1-34) is also known to influence osteoclast maturation and activity through modulation of osteoblast-derived cytokines, such as receptor activator of nuclear factor-kappaB ligand (RANKL), osteoprotegerin (OPG), IL-6, and IL-6 soluble receptor (IL-6sR). In this experiment, we investigated the changes in serum levels of soluble RANKL (sRANKL), OPG, IL-6, and IL-6sR in patients with glucocorticoid-induced osteoporosis treated with hPTH (1-34). Fifty-one postmenopausal women with glucocorticoid-induced osteoporosis were randomized to receive 12 months of 400 U hPTH (1-34) ( approximately 40 microg) daily and standard hormone replacement therapy, or hormone replacement therapy alone. Serum levels of sRANKL, OPG, IL-6, and IL-6sR were measured at baseline, 1 month, and every 3 months thereafter for a total of 24 months. hPTH (1-34) caused a rapid and significant increase in sRANKL within 1 month, and the levels remained elevated throughout the duration of therapy. IL-6 and IL-6sR increased significantly within 1 month, but returned to baseline levels more...Continue Reading

References

Aug 30, 1991·Biochemical and Biophysical Research Communications·N H LiH Orimo
Jun 1, 1996·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·J H PollockE M Greenfield
May 10, 2000·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·J E OnyiaT J Martin
Jul 27, 2000·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·N E LaneC D Arnaud
Feb 15, 2001·American Journal of Physiology. Endocrinology and Metabolism·M A MitnickK Insogna
Nov 20, 2001·Endocrinology·S Khosla
Jun 7, 2002·The Journal of Clinical Endocrinology and Metabolism·Urszula S MasiukiewiczKarl L Insogna
Nov 5, 2002·The Journal of Clinical Endocrinology and Metabolism·Inaam A NakchbandiKarl Insogna
Apr 12, 2003·Journal of Cellular Biochemistry·Rachel M LocklinB Lawrence Riggs
Sep 23, 2003·The New England Journal of Medicine·Dennis M BlackUNKNOWN PaTH Study Investigators
Sep 23, 2003·The New England Journal of Medicine·Joel S FinkelsteinRobert M Neer

❮ Previous
Next ❯

Citations

Sep 1, 2005·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·Marja HurleyNancy E Lane
Jun 15, 2007·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·E CanalisJ P Bilezikian
Dec 2, 2010·Cell and Tissue Research·Anna NeveFrancesco Paolo Cantatore
Aug 3, 2010·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Pornpimol RianthavornBeatriz D Kuizon
Aug 18, 2010·Wiener medizinische Wochenschrift·Doris Wagner, Astrid Fahrleitner-Pammer
Jun 30, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Yoshiko Iwasaki-IshizukaMasafumi Fukagawa
Sep 3, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Yunshan GuoYan Peng
Jun 18, 2011·Rheumatology·Nancy E Lane
Jun 16, 2005·Current Opinion in Rheumatology·Nancy Lane, Stephen Morris
Jan 1, 2010·BMJ Case Reports·Anna-Mari KoskiTerje Forslund
Feb 1, 2009·Therapeutic Advances in Musculoskeletal Disease·Gherardo MazziottiJohn P Bilezikian
Jun 6, 2009·Arthritis Research & Therapy·Nancy E Lane, Wei Yao
Dec 13, 2007·The Journal of Clinical Endocrinology and Metabolism·Inaam A NakchbandiKarl L Insogna
Aug 27, 2009·Biologics : Targets & Therapy·E Michael Lewiecki
Jun 19, 2009·Therapeutics and Clinical Risk Management·Silvia MigliaccioNazzarena Malavolta
Jul 25, 2009·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Stephanie K A BlickSusan J Keam
Sep 14, 2006·Calcified Tissue International·T P van Staa
Sep 23, 2006·Expert Opinion on Biological Therapy·E Michael Lewiecki
Jun 30, 2009·Expert Opinion on Investigational Drugs·Athanasios D AnastasilakisEvangelos Terpos
Jan 30, 2016·Metabolic Syndrome and Related Disorders·Ramin Alemzadeh, Jessica Kichler
Dec 23, 2008·São Paulo Medical Journal = Revista Paulista De Medicina·Virgínia Fernandes Moça TrevisaniAlvaro Nagib Atallah
Jan 23, 2008·Arquivos brasileiros de endocrinologia e metabologia·Gherardo MazziottiJohn P Bilezikian
Jul 3, 2008·Translational Research : the Journal of Laboratory and Clinical Medicine·Xiaohu ZhuHanjun Tu
Jan 27, 2006·World Journal of Gastroenterology : WJG·Silvio DaneseAntonio Gasbarrini
Oct 1, 2008·Circulation·Diane E WallisGlen W Sizemore
Feb 3, 2007·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Xin ChenEdward M Greenfield
Dec 20, 2008·Drugs·Stephanie K A BlickSusan J Keam
Nov 17, 2006·Journal of the American Society of Nephrology : JASN·John Cunningham
Jun 7, 2007·The Journal of Clinical Endocrinology and Metabolism·F JosephW D Fraser
Mar 4, 2008·The Journal of Bone and Joint Surgery. British Volume·H R JohanssonP Aspenberg
Jan 1, 2008·Clinical Medicine. Case Reports·Terje ForslundAnu Sikiö
Nov 21, 2012·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Cristiana CiprianiJohn P Bilezikian
Sep 8, 2011·Oral Diseases·P Aggarwal, A Zavras
Jul 14, 2006·Molecular and Cellular Biochemistry·Sun Hee DoKyu-Shik Jeong
Jun 24, 2006·Current Opinion in Obstetrics & Gynecology

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.